celgene corp (CELG:NASDAQ GS)
Thomas O. Daniel M.D.
President of Research & Early Development and Executive Vice President, Celgene Corporation
|Age||Total Calculated Compensation||This person is connected to 28 board members in 2 different organizations across 6 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Thomas O. Daniel, M.D., has been the President of Research & Early development of Celgene Corporation since December 2006 and also served as its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen ...
86 Morris AvenuePhone: 908-673-9000
Summit, New Jersey 07901
Board Members Memberships*
University of Texas Southwestern Medical Center - Dallas
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Flemming Ornskov M.D., MBA, MPH||Chief Executive Officer, Managing Director and Director|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|